A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity

Clinical trial NCT06916065 · COMPLETED

Trial details

NCT number: NCT06916065
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Overweight Obesity

Start date: 2025-04-09
Primary completion: 2026-01-19
Enrollment: 188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.